Shin DY - Search Results

1

Prevalent factor XII deficiency in cancer patients with isolated aPTT prolongation.

Shin DY, Lee HR, Kang HJ, Na II, Chang YH, Yang SH. Shin DY, et al. Blood Res. 2015 Jun;50(2):114-7. doi: 10.5045/br.2015.50.2.114. Epub 2015 Jun 25. Blood Res. 2015. PMID: 26157783 Free PMC article. No abstract available.

2

Clinical characteristics and outcomes of primary bone lymphoma in Korea.

Kim SY, Shin DY, Lee SS, Suh C, Kwak JY, Kim HG, Lee JH, Lee SI, Lee YR, Kang SH, Mun SK, Lee MJ, Lee HR, Yang SH, Kang HJ. Kim SY, et al. Among authors: shin dy. Korean J Hematol. 2012 Sep;47(3):213-8. doi: 10.5045/kjh.2012.47.3.213. Epub 2012 Sep 25. Korean J Hematol. 2012. PMID: 23071477 Free PMC article.

3

Repeated radioimmunotherapy with 131I-rituximab for patients with low-grade and aggressive relapsed or refractory B cell non-Hodgkin lymphoma.

Kang HJ, Lee SS, Byun BH, Kim KM, Lim I, Choi CW, Suh C, Kim WS, Nam SH, Lee SI, Eom HS, Shin DY, Lim SM. Kang HJ, et al. Among authors: shin dy. Cancer Chemother Pharmacol. 2013 Apr;71(4):945-53. doi: 10.1007/s00280-013-2087-z. Epub 2013 Jan 31. Cancer Chemother Pharmacol. 2013. PMID: 23370662 Clinical Trial.

4

EGFR mutation and brain metastasis in pulmonary adenocarcinomas.

Shin DY, Na II, Kim CH, Park S, Baek H, Yang SH. Shin DY, et al. J Thorac Oncol. 2014 Feb;9(2):195-9. doi: 10.1097/JTO.0000000000000069. J Thorac Oncol. 2014. PMID: 24419416 Free article.

5

Family caregivers' awareness of illness and attitude toward disclosure during chemotherapy for advanced cancer.

Kim S, Ko Y, Kwon S, Shin DY, Kim CH, Yang SH, Cho SJ, Na II. Kim S, et al. Among authors: shin dy. Psychooncology. 2014 Nov;23(11):1300-6. doi: 10.1002/pon.3565. Epub 2014 May 12. Psychooncology. 2014. PMID: 24816481

6

Radioimmunotherapy with (131)i-rituximab in a patient with diffuse large B-cell lymphoma relapsed after treatment with (90)y-ibritumomab tiuxetan.

Kang GW, Kang HJ, Shin DY, Gu HR, Choi HS, Lim SM. Kang GW, et al. Among authors: shin dy. Nucl Med Mol Imaging. 2013 Dec;47(4):281-4. doi: 10.1007/s13139-013-0229-1. Epub 2013 Aug 30. Nucl Med Mol Imaging. 2013. PMID: 24900126 Free PMC article.

7

Serum 25-hydroxyvitamin D levels correlate with EGFR mutational status in pulmonary adenocarcinoma.

Shin DY, Kim S, Park S, Koh JS, Kim CH, Baek H, Yang SH, Na II. Shin DY, et al. Endocr Relat Cancer. 2014 Oct;21(5):715-21. doi: 10.1530/ERC-14-0259. Epub 2014 Jul 16. Endocr Relat Cancer. 2014. PMID: 25030993

8

Histone deacetylase inhibitor romidepsin induces efficient tumor cell lysis via selective down-regulation of LMP1 and c-myc expression in EBV-positive diffuse large B-cell lymphoma.

Shin DY, Kim A, Kang HJ, Park S, Kim DW, Lee SS. Shin DY, et al. Cancer Lett. 2015 Aug 10;364(2):89-97. doi: 10.1016/j.canlet.2015.03.016. Epub 2015 Mar 16. Cancer Lett. 2015. PMID: 25790907

9

HBV reactivation in a HBsAg-negative patient with multiple myeloma treated with prednisolone maintenance therapy after autologous HSCT.

Gu HR, Shin DY, Choi HS, Moon CH, Park SC, Kang HJ. Gu HR, et al. Among authors: shin dy. Blood Res. 2015 Mar;50(1):51-3. doi: 10.5045/br.2015.50.1.51. Epub 2015 Mar 24. Blood Res. 2015. PMID: 25830131 Free PMC article.

10

The utility of the serum heavy/light chain assay as a complementary tool in the monitoring of patients with plasma cell myeloma: a report of three cases.

Kim H, Lee JK, Hong YJ, Hong SI, Shin DY, Kang HJ, Chang YH. Kim H, et al. Among authors: shin dy. Ann Clin Lab Sci. 2015 Spring;45(2):193-8. Ann Clin Lab Sci. 2015. PMID: 25887874

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

460 results

Search Page